Vontier (VNT) Competitors $37.51 +0.30 (+0.80%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VNT vs. AVTR, RVTY, BIO.B, NVMI, ST, CAMT, MIR, TXG, TRNS, and CTKBShould you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Sensata Technologies (ST), Camtek (CAMT), Mirion Technologies (MIR), 10x Genomics (TXG), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry. Vontier vs. Avantor Revvity Bio-Rad Laboratories Nova Sensata Technologies Camtek Mirion Technologies 10x Genomics Transcat Cytek Biosciences Avantor (NYSE:AVTR) and Vontier (NYSE:VNT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership. Which has more volatility and risk, AVTR or VNT? Avantor has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Vontier has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Is AVTR or VNT more profitable? Vontier has a net margin of 13.54% compared to Avantor's net margin of 4.54%. Vontier's return on equity of 45.48% beat Avantor's return on equity.Company Net Margins Return on Equity Return on Assets Avantor4.54% 12.24% 5.15% Vontier 13.54%45.48%10.49% Does the media prefer AVTR or VNT? In the previous week, Vontier had 1 more articles in the media than Avantor. MarketBeat recorded 12 mentions for Vontier and 11 mentions for Avantor. Avantor's average media sentiment score of 0.60 beat Vontier's score of 0.37 indicating that Avantor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avantor 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Vontier 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals have more ownership in AVTR or VNT? 95.1% of Avantor shares are held by institutional investors. Comparatively, 95.8% of Vontier shares are held by institutional investors. 1.3% of Avantor shares are held by company insiders. Comparatively, 0.8% of Vontier shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in AVTR or VNT? Avantor received 140 more outperform votes than Vontier when rated by MarketBeat users. Likewise, 65.12% of users gave Avantor an outperform vote while only 51.81% of users gave Vontier an outperform vote. CompanyUnderperformOutperformAvantorOutperform Votes18365.12% Underperform Votes9834.88% VontierOutperform Votes4351.81% Underperform Votes4048.19% Which has stronger earnings & valuation, AVTR or VNT? Vontier has lower revenue, but higher earnings than Avantor. Vontier is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvantor$6.97B2.14$321.10M$0.4647.55Vontier$2.99B1.89$376.90M$2.6114.40 Do analysts recommend AVTR or VNT? Avantor currently has a consensus price target of $27.38, indicating a potential upside of 25.19%. Vontier has a consensus price target of $44.63, indicating a potential upside of 18.73%. Given Avantor's stronger consensus rating and higher possible upside, equities analysts clearly believe Avantor is more favorable than Vontier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avantor 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.77Vontier 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63 SummaryAvantor beats Vontier on 11 of the 18 factors compared between the two stocks. Get Vontier News Delivered to You Automatically Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VNT vs. The Competition Export to ExcelMetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE ExchangeMarket Cap$5.65B$6.00B$7.65B$19.95BDividend Yield0.28%0.47%2.34%3.71%P/E Ratio14.4033.9328.0141.51Price / Sales1.895.45437.6817.17Price / Cash9.5630.0229.1419.82Price / Book6.489.376.245.75Net Income$376.90M$234.75M$133.93M$994.45M7 Day Performance4.55%4.20%1.68%3.27%1 Month Performance-1.46%-3.21%4.00%2.00%1 Year Performance10.84%27.76%26.01%19.66% Vontier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VNTVontier3.8925 of 5 stars$37.51+0.8%$44.63+19.0%+9.0%$5.63B$2.99B14.378,000Short Interest ↓AVTRAvantor4.0199 of 5 stars$22.10+2.0%$27.69+25.3%+3.5%$15.04B$6.82B48.0414,500Analyst ForecastOptions VolumeNews CoverageHigh Trading VolumeRVTYRevvity3.594 of 5 stars$122.76+7.8%$131.93+7.5%+10.4%$14.94B$2.72B59.3011,500BIO.BBio-Rad LaboratoriesN/A$341.00flatN/A+7.5%$9.55B$2.58B-12.488,200NVMINova1.7939 of 5 stars$217.85+0.1%$238.33+9.4%+81.4%$6.33B$611.85M40.643,606Analyst RevisionNews CoverageSTSensata Technologies4.734 of 5 stars$27.44+0.7%$41.00+49.4%-17.4%$4.10B$4.02B-50.8120,800Analyst ForecastNews CoverageCAMTCamtek3.7929 of 5 stars$86.79-3.0%$110.78+27.6%+33.6%$3.94B$400.63M40.00400Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageGap UpMIRMirion Technologies2.7832 of 5 stars$15.89flat$19.25+21.1%+69.2%$3.69B$836.90M-46.743,000Gap DownTXG10x Genomics4.5739 of 5 stars$15.71+0.8%$23.86+51.9%-66.1%$1.90B$629.74M-10.271,240News CoverageGap UpTRNSTranscat3.134 of 5 stars$103.49+0.9%$130.25+25.9%+6.3%$952.01M$270.61M52.27920CTKBCytek Biosciences2.737 of 5 stars$7.21+5.7%$9.25+28.3%-31.5%$928.73M$201.21M-90.11500News CoveragePositive News Related Companies and Tools Related Companies Avantor Competitors Revvity Competitors Bio-Rad Laboratories Competitors Nova Competitors Sensata Technologies Competitors Camtek Competitors Mirion Technologies Competitors 10x Genomics Competitors Transcat Competitors Cytek Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:VNT) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vontier Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vontier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.